Hamilton Thorne (CVE:HTL) Trading 4.3% Higher – Should You Buy?
by Doug Wharley · The Cerbat GemHamilton Thorne Ltd. (CVE:HTL – Get Free Report)’s stock price traded up 4.3% on Thursday . The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares traded hands during mid-day trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Performance
The company has a current ratio of 2.63, a quick ratio of 2.25 and a debt-to-equity ratio of 33.94. The stock has a market cap of C$212.89 million, a PE ratio of 48.33 and a beta of 0.54. The business’s 50-day moving average price is C$1.45 and its 200-day moving average price is C$1.45.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets.
Featured Stories
- Five stocks we like better than Hamilton Thorne
- What is the Hang Seng index?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Investing In Preferred Stock vs. Common Stock
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines